VRS
NRIX icon

Virginia Retirement Systems’s Nurix Therapeutics NRIX Stock Holding History

Virginia Retirement Systems’s Portfolio NRIX Stock Details NRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-12,400
Closed -$141K – 1013
2025
Q2 		$141K Sell
12,400
-3,600
-23% -$38.9K ﹤0.01% 916
2025
Q1 		$190K Buy
+16,000
New +$268K ﹤0.01% 969

Other funds holding NRIX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Virginia Retirement Systems's NRIX Position: Q3 2025 in Review

Virginia Retirement Systems sold out of Nurix Therapeutics (NRIX) in Q3 2025, closing a stake of 12,400 shares — an estimated $141K sold.

Virginia Retirement Systems first reported a position in NRIX in Q1 2025 and held it in 2 quarters. The position peaked at $190K in Q1 2025. 173 funds tracked by Wall St. Rank hold NRIX as of Q3 2025.

  • Virginia Retirement Systems reported no remaining Nurix Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Virginia Retirement Systems sold 12,400 Nurix Therapeutics shares in Q3 2025, an estimated $141K.
  • Virginia Retirement Systems first reported a position in Nurix Therapeutics in Q1 2025 and held it in 2 quarters.
  • Virginia Retirement Systems's Nurix Therapeutics position peaked at $190K in Q1 2025.
  • 173 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q3 2025.

Based on Virginia Retirement Systems's 13F filing for Q3 2025, filed 20 Oct 2025.